Plain-English translation of NCT07363590 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a new medication called in people who have either lupus or rheumatoid arthritis. The main goal is to understand how safe this medication is and how well people tolerate it when given at different dose levels. Researchers will carefully watch for any side effects and measure how the medication moves through your body.
Lupus and rheumatoid arthritis are serious conditions that cause inflammation and pain, and current treatments don't work well for everyone. This medication is being tested to see if it could offer a new treatment option for people with these conditions.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic to receive IV injections of the medication at different dose levels. In the first part of the study, you would receive a single dose. In later parts, you would receive doses over a 3-week period (a prime dose, a step-up dose, and a target dose). Throughout the study, doctors would monitor you closely with blood tests and check-ins to watch for any side effects and see how your body responds to the medication.
AI-generated summary from trial data · Sep 16, 2026 · Not medical advice
Australia
Belgium
China